c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma

BACKGROUND: Activation of the c-Met pathway occurs in a range of malignancies, including papillary renal cell carcinoma (RCC). Its activity in clear cell RCC is less clear. We investigated c-Met expression and inhibition in a large cohort of RCC tumors and cell lines. METHODS: c-Met protein expressi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gibney, G. T., Aziz, S. A., Camp, R. L., Conrad, P., Schwartz, B. E., Chen, C. R., Kelly, W. K., Kluger, H. M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551486/
https://ncbi.nlm.nih.gov/pubmed/23022995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mds463
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars